Your browser doesn't support javascript.
loading
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Dutta, Ankit K; Alberge, Jean-Baptiste; Lightbody, Elizabeth D; Boehner, Cody J; Dunford, Andrew; Sklavenitis-Pistofidis, Romanos; Mouhieddine, Tarek H; Cowan, Annie N; Su, Nang Kham; Horowitz, Erica M; Barr, Hadley; Hevenor, Laura; Beckwith, Jenna B; Perry, Jacqueline; Cao, Amanda; Lin, Ziao; Kuhr, Frank K; Mastro, Richard G Del; Nadeem, Omar; Greipp, Patricia T; Stewart, Chip; Auclair, Daniel; Getz, Gad; Ghobrial, Irene M.
Afiliación
  • Dutta AK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Alberge JB; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Lightbody ED; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Boehner CJ; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Dunford A; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Sklavenitis-Pistofidis R; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Mouhieddine TH; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cowan AN; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Su NK; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Horowitz EM; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Barr H; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Hevenor L; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Beckwith JB; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Perry J; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cao A; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Lin Z; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Kuhr FK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mastro RGD; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Nadeem O; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Greipp PT; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stewart C; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Auclair D; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Getz G; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Ghobrial IM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Cancer Discov ; 13(2): 348-363, 2023 02 06.
Article en En | MEDLINE | ID: mdl-36477267
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Células Neoplásicas Circulantes Límite: Humans Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Células Neoplásicas Circulantes Límite: Humans Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos